Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets
By Billy Gray
Germany's Merck KGaA said it is targeting annual organic sales growth in the mid-single-digit percentage range and an expansion in profitability over the medium term, and confirmed its 2025 guidance.
The German chemicals and life-science company said Thursday that it backed its earlier guidance for 2025, which called for organic growth in net sales of 3% to 6% and in earnings before interest, taxes, depreciation and amortization before exceptional items of 3% to 7%.
Over the medium term, Merck said it targets annual organic sales growth in the mid single-digit percentage range and an expansion in its Ebitda pre-exceptional margin of one percentage point. For 2024, the company reported an Ebitda margin before exceptional items of 28.7%.
"We are sharply focused on growth and well-positioned in attractive markets through a combination of organic investments and a string of targeted acquisitions of companies delivering breakthrough solutions," said Merck CEO Belen Garijo.
Write to Billy Gray at william.gray@wsj.com
(END) Dow Jones Newswires
October 16, 2025 01:59 ET (05:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States